|
original article |
Date |
Title |
Authors Max. 6 Authors |
1 |
[GO] |
2024―Sep―27 |
Effects of an 8-week intervention of anulom vilom pranayama combined with heartfulness meditation on psychological stress, autonomic function, inflammatory biomarkers, and oxidative stress in healthcare workers during COVID-19 pandemic: a randomized controlled trial |
Vivek Kumar Sharma, Pradip B Barde, Rajesh Kathrotia, Gaurav Sharma, Vinay Chitturi, Naresh Parmar, Gauravi Dhruva, Ghanshyam Kavathia, Rajathi Rajendran |
2 |
[GO] |
2024―Sep―18 |
Uncovering the coronavirus outbreak: present understanding and future research paths |
Jayati Roy, Arnab Banerjee, Sandip Mukherjee, Bithin K. Maji |
3 |
[GO] |
2023―Jul―18 |
Lung ultrasound-guided PEEP titration in COVID-19 patients treated with CPAP |
Giorgio Bosso, Gennaro Sansone, Martina Papillo, Alessandro Giaquinto, Silvia Orefice, Enrico Allegorico, Claudia Serra, Valentina Minerva, Valentina Mercurio, Francesca Cannavacciuolo, Ferdinando Dello Vicario, Giovanni Porta, Antonio Pagano, Fabio Giuliano Numis |
4 |
[GO] |
2023―Mar―23 |
Importance of moderate-to-vigorous physical activity during the COVID-19 pandemic: a systematic review and meta-analysis |
Purwo Sri Rejeki, Bendix Samarta Witarto, Andro Pramana Witarto, Salsabila Nabilah Rifdah, Ifan Ali Wafa, Dita Mega Utami, Nabilah Izzatunnisa, Citrawati Dyah Kencono Wungu, Siti Khaerunnisa, Nur Ezza Fazleen Mohd Fathil |
5 |
[GO] |
2023―Jan―06 |
Bispecific antibodies and its applications: a novel approach for targeting SARS-Cov-2 |
Ajay Kumar Shukla, Saurav Misra |
6 |
[GO] |
2022―Oct―21 |
Clinical implications of anti-idiotype antibodies in COVID-19 |
Ajay Kumar Shukla, Saurav Misra |
7 |
[GO] |
2022―May―03 |
Antimicrobials in COVID-19: strategies for treating a COVID-19 pandemic |
Ajay Kumar Shukla, Saurav Misra |
8 |
[GO] |
2022―Apr―07 |
A hypothesis that Notopterol may be effective in COVID-19 via JAK/STAT and other signaling pathways |
Fereshteh Nazari-Khanamiri, Morteza Ghasemnejad-Berenji |
9 |
[GO] |
2022―Jan―07 |
Antibody-dependent enhancement of virus infection and disease: implications in COVID-19 |
Ajay Kumar Shukla, Saurav Misra |
10 |
[GO] |
2022―Jan―07 |
Hydroxychloroquine pre-exposure prophylaxis provides no protection against COVID-19 among health care workers: a cross-sectional study in a tertiary care hospital in North India |
Shivani Juneja, Proteesh Rana, Parvinder Chawala, Rekha Katoch, Kulvir Singh, Shobha Rana, Tamanna Mittal, Bhavnish Kaur, Simaranjot Kaur |
11 |
[GO] |
2021―Dec―09 |
Using of calcium channel blockers in patients with COVID-19: a magic bullet or a double-edged sword? |
Sonia Sadeghpopur, Hojat Ghasemnejad-Berenji, Sarvin Pashapour, Morteza Ghasemnejad-Berenji |
12 |
[GO] |
2021―Dec―02 |
Can sulfasalazine as an old drug with immunomodulatory and anti-inflammatory effects be effective in COVID-19? |
Morteza Ghasemnejad-Berenji |
13 |
[GO] |
2021―Nov―27 |
Perspectives into the possible effects of the B.1.1.7 variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on spermatogenesis |
Andrea M. T. Kallumadyil, Tess McClenahan, Samantha De Filippis, Ananya Vungarala, Nihal Satyadev, Robert S. Waters, Anand L. Kulkarni |
14 |
[GO] |
2021―Oct―29 |
COVID-19 disease in clinical setting: impact on gonadal function, transmission risk, and sperm quality in young males |
Fabrizio I. Scroppo, Elisabetta Costantini, Alessandro Zucchi, Ester Illiano, Francesco Trama, Stefano Brancorsini, Felice Crocetto, Maria Rita Gismondo, Federico Dehò, Anna Mercuriali, Riccardo Bartoletti, Francesco Gaeta |
15 |
[GO] |
2021―Sep―25 |
The “Delta Plus” COVID-19 variant has evolved to become the next potential variant of concern: mutation history and measures of prevention |
Fahad Imtiaz Rahman, Sadia Afruz Ether, Md. Rabiul Islam |
16 |
[GO] |
2021―Sep―13 |
Characteristics and management of asymptomatic SARS-CoV-2 infections |
Mine Durusu Tanriover, Anahita Fathi, Matthias Raspe, António Grilo Novais, Oğuz Abdullah Uyaroğlu |
17 |
[GO] |
2021―Aug―11 |
Vitamin supplementation as a potential adjunctive therapeutic approach for COVID-19: biological and clinical plausibility |
Amin Daei Sorkhabi, Aila Sarkesh, Alireza Daei Sorkhabi, Taher Entezari-Maleki, Jalil Rashedi, Hossein Bannazadeh Baghi |
18 |
[GO] |
2021―Jul―22 |
Increase in SARS-CoV-2 infected biomedical waste among low middle-income countries: environmental sustainability and impact with health implications |
Olugbemi T. Olaniyan, Ayobami Dare, Bamidele Okoli, Charles O. Adetunji, Babatunde O. Ibitoye, Gloria E. Okotie, Olugbenga Eweoya |
19 |
[GO] |
2021―Jul―19 |
A dossier on COVID-19 chronicle |
Tarique Mahmood, Ismail Kedwai, Farogh Ahsan, Arshiya Shamim, Mohammad Shariq, Saba Parveen |
20 |
[GO] |
2021―Jul―15 |
Computational drug repurposing study of antiviral drugs against main protease, RNA polymerase, and spike proteins of SARS-CoV-2 using molecular docking method |
Alireza Jalalvand, Somayeh Behjat Khatouni, Zahra Bahri Najafi, Foroozan Fatahinia, Narges Ismailzadeh, Behrokh Farahmand |
21 |
[GO] |
2021―Jul―04 |
A new application of mTOR inhibitor drugs as potential therapeutic agents for COVID-19 |
Habibeh Mashayekhi-Sardoo, Hesamoddin Hosseinjani |
22 |
[GO] |
2021―Jul―02 |
Knowledge, attitudes, and practices (KAP) towards COVID-19 among university students in Pakistan: a cross-sectional study |
Shah Faisal, Junaidi Khotib, Elida Zairina |
23 |
[GO] |
2021―Jul―02 |
Phyllanthin and hypophyllanthin, the isolated compounds of Phyllanthus niruri inhibit protein receptor of corona virus (COVID-19) through in silico approach |
Honey Dzikri Marhaeny, Aty Widyawaruyanti, Tri Widiandani, Achmad Fuad Hafid, Tutik Sri Wahyuni |
24 |
[GO] |
2021―Jun―30 |
COVID-19 infection in children with underlying malignancies in Iran |
Amene Navaeian, Shima Mahmoudi, Babak Pourakbari, Maryam Bakhtiari, Mahmoud Khodabandeh, Mohammad Reza Abdolsalehi, Alieh Safari Sharari, Setareh Mamishi |
25 |
[GO] |
2021―May―21 |
Environmental and climatic impact on the infection and mortality of SARS-CoV-2 in Peru |
Victor J. Samillan, Diana Flores-León, Eduardo Rojas, Brian R. Zutta |
26 |
[GO] |
2021―Apr―29 |
Irrational pharmacy practice and inadequate health care services in Bangladesh: a lesson learned from COVID-19 pandemic |
Md. Jakaria, Shofiul Azam, Shafayet Ahmed Siddiqui, Mohammad Injamul Hoq, Mohammad Safiqul Islam |
27 |
[GO] |
2021―Mar―11 |
Characterization of cardiac autonomic function in COVID-19 using heart rate variability: a hospital based preliminary observational study |
Deepalakshmi Kaliyaperumal, Karthikeyan RK, Murali Alagesan, Sudha Ramalingam |
28 |
[GO] |
2021―Feb―18 |
In silico approach: docking study of oxindole derivatives against the main protease of COVID-19 and its comparison with existing therapeutic agents |
Vraj R. Shah, Jaydip D. Bhaliya, Gautam M. Patel |
29 |
[GO] |
2021―Feb―18 |
Evidence that Ginkgo Biloba could use in the influenza and coronavirus COVID-19 infections |
Manal A. Ibrahim, Hanan H. Ramadan, Rasha N. Mohammed |
30 |
[GO] |
2020―Dec―22 |
Therapeutic clinical trials to combat COVID-19 pandemic in India: analysis from trial registry |
Angelika Batta, Raj Khirasaria, Vinod Kapoor, Deepansh Varshney |
31 |
[GO] |
2020―Oct―05 |
Testis and blood-testis barrier in Covid-19 infestation: role of angiotensin-converting enzyme 2 in male infertility |
Olugbemi T. Olaniyan, Ayobami Dare, Gloria E. Okotie, Charles O. Adetunji, Babatunde O Ibitoye, Okoli J. Bamidele, Olugbenga O. Eweoya |
32 |
[GO] |
2020―Sep―14 |
An evidence-based systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario |
Anupama M. Gppanavar, Jyoti Benni |
33 |
[GO] |
2020―Sep―11 |
Is COVID-19 spreading and curing silently: an observation of three family clusters in Bangladesh |
Mohammad Injamul Hoq, Md. Mohotasin Hossain, Umme Sayma Roshni, Mohammed Aktar Sayeed, Saraban Tohura, Md. Jakaria |
34 |
[GO] |
2020―Sep―11 |
SARS-CoV-2 infection, oxidative stress and male reproductive hormones: can testicular-adrenal crosstalk be ruled-out? |
Sulagna Dutta, Pallav Sengupta |